Jazz Wades Into Cannabinoid Weeds With $7.2bn GW Buy

Epilepsy Drug Epidiolex Adds To Sleep, Oncology Franchises

Merging, two merchants push the red squares and other squares together
Sales of Epidiolex last year equal almost a quarter of Jazz's expected 2020 revenue • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business